Profil
Thomas C.
Gallagher currently works at Genprex, Inc., as Senior VP-Intellectual Property & Licensing from 2020.
Mr. Gallagher also formerly worked at ImClone LLC, as Vice President-Intellectual Property & Licensing, Caladrius Biosciences, Inc., as Counsel, and Kadmon Corp.
LLC, as Senior VP-Intellectual Property & Licensing.
Postes actifs de Thomas C. Gallagher
| Sociétés | Poste | Début |
|---|---|---|
| GENPREX, INC. | Corporate Officer/Principal | 21/09/2020 |
Anciens postes connus de Thomas C. Gallagher
| Sociétés | Poste | Fin |
|---|---|---|
Kadmon Corp. LLC
Kadmon Corp. LLC Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Corporate Officer/Principal | - |
Caladrius Biosciences, Inc.
Caladrius Biosciences, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops and commercializes cellular therapies products | Corporate Officer/Principal | - |
ImClone LLC
ImClone LLC BiotechnologyHealth Technology Develops novel therapeutic products and blood cell growth factors for the treatment of cancer | Corporate Officer/Principal | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
ImClone LLC
ImClone LLC BiotechnologyHealth Technology Develops novel therapeutic products and blood cell growth factors for the treatment of cancer | Health Technology |
Genprex, Inc.
Genprex, Inc. Pharmaceuticals: MajorHealth Technology Develops molecular therapies for cancer treatment | Health Technology |
Caladrius Biosciences, Inc.
Caladrius Biosciences, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops and commercializes cellular therapies products | Health Technology |
Kadmon Corp. LLC
Kadmon Corp. LLC Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
















